Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
[1] Important safety considerations include a boxed warning for thyroid C-cell tumors (medullary thyroid carcinoma/MEN2), and warnings for pancreatitis and gallbladder disease
"Much ado about nothing: the peptide they say never worked"
GLP-1 receptor activation Reduces appetite by slowing gastric emptying and enhancing satiety signals to the brain, while improving glucose-dependent insulin secretion
Injectable GHK-Cu, now legally compoundable after the April 2026 reclassification, requires a physicians prescription from a licensed 503A compounding pharmacy following USP 797 sterile compounding standards
Proper injection technique matters regardless of which medication you use
